Verified peer comparison
Aktis Oncology vs Adial Pharmaceuticals Financial Comparison
Direct answer
Aktis Oncology and Adial Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Aktis Oncology Revenue
- 6,497,000 USD
- Adial Pharmaceuticals Revenue
- 0 USD
- Aktis Oncology Operating income
- -74,684,000 USD
- Adial Pharmaceuticals Operating income
- -7,799,462 USD